Jan. 30, 2009-A decision by the U.S district court judge in Minnesota on January 28 largely rules in Biotec Pharmacon's favour in the patent infringement suit brought by Biopolymer Engineering, Inc. d/b/a Biothera against Biotec Pharmacon ASA and its U.S. affiliate, Immunocorp. The decision eliminates from further litigation all of Biothera's claims under 12 of the 14 U.S. patents at issue in the case.
The details can be read here.
No comments:
Post a Comment